Breadcrumb

RESP  |  Translational Research in Respiratory Diseases Program

RESP Program News

We are proud to celebrate the scientific achievements of our researchers and trainees in publications, grant competitions, honors and awards, and appointments, as well as in the mainstream press.

Scientists from McGill University and the Research Institute of the MUHC visit Braunschweig

Delegation takes part in a working visit to the Helmholtz Centre for Infection Research (HZI)

Seven RI-MUHC researchers among the 2019 Canadian Academy of Health Sciences new Fellows

Inductees are honoured for leadership in the health sciences

So much to discover: Research in the era of legal cannabis

Interview with Carolyn Baglole, director of the new McGill Research Centre for Cannabis

All programs on board in 2019 for RI-MUHC Summer Student Research Day

Congratulations to students who contributed to the scientific life of our institute this summer!

RI-MUHC postdoc Dorival Martins, Jr., honoured by the FRQS

Study aims to lighten the burden of persistent infections in people living with cystic fibrosis

Congratulations to our winners at the 30th Annual RI-MUHC Respiratory Research Day!

On June 3, the Translational Research in Respiratory Diseases Program at the RI-MUHC welcomed their members to the 30th Annual Respiratory Research Day.

The Centre for Outcomes Research and Evaluation’s third Annual Research Day was a success!

The May 14 event organized by the Centre for Outcomes Research and Evaluation (CORE) provided an opportunity for trainees from all eight RI-MUHC programs to share their work and discoveries.

Canadian researchers on promising path towards developing flu treatment using lipid target

A team of scientists from the RI-MUHC recently identified a target to “tone down” the hyperactive immunity to influenza infection

Dick Menzies receives Distinguished Lecturer Award in Respiratory Sciences

The CIHR-ICRH/CTS lectureship honours Dr. Menzies’s significant contributions in tuberculosis research, both in Canada and internationally

Anti-TB drugs can increase risk of TB re-infection

Treatment leads to changes in gut microbiota, compromising immunity

Explore news and events at the RI-MUHC